Nasdaq

Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study

SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 ...
PharmiWeb

Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule

SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
PharmiWeb

Modular Medical Announces Proposed Public Offering

SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed ...
Finanznachrichten

Modular Medical, Inc.: Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule

SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...